[1]
|
Collins, G., Essary, L., Strauss, J., Hino, P. and Cockerell, C.J. (2012) Incidentally Discovered Distant Cutaneous Metastasis of Sacral Chordoma: A Case with Variation in S100 Protein Expression (Compared to the Primary Tumor) and Review of the Literature. Journal of Cutaneous Pathology, 39, 637-643.
https://doi.org/10.1111/j.1600-0560.2012.01895.x
|
[2]
|
Rubin, A., Bagel, J. and Niedt, G. (2005) Chordoma Cutis. Journal of the American Academy of Dermatology, 52, S105-S108. https://doi.org/10.1016/j.jaad.2004.07.055
|
[3]
|
Antonelli, M., Raso, A., Mascelli, S., Marco, G., Paolo, N., Antonella, C., et al. (2017) SMARCB1/INI1 Involvement in Pediatric Chordoma: A Mutational and Immunohistochemical Analysis. The American Journal of Surgical Pathology, 41, 56-61. https://doi.org/10.1097/PAS.0000000000000741
|
[4]
|
Stark, A.M. and Mehdorn, H.M. (2003) Chondroid Clival Chordoma. New England Journal of Medicine, 349, e10. https://doi.org/10.1056/ENEJMicm010745
|
[5]
|
Bakker, S.H., Jacobs, W.C.H., Pondaag, W., Gelderblom, H., Nout, R.A., Dijkstra, P.D.S., et al. (2018) Chordoma: A Systematic Review of the Epidemiology and Clinical Prognostic Factors Predicting Progression-Free and Overall Survival. European Spine Journal, 27, 3043-3058. https://doi.org/10.1007/s00586-018-5764-0
|
[6]
|
McMaster, M.L., Goldstein, A.M., Bromley, C.M., Ishibe, N. and Parry, D.M. (2001) Chordoma: Incidence and Survival Patterns in the United States, 1973-1995. Cancer Causes & Control, 12, 1-11. https://doi.org/10.1023/A:1008947301735
|
[7]
|
Walcott, B.P., Nahed, B.V., Mohyeldin, A., Coumans, J.-V., Kahle, K.T. and Ferreira, M.J. (2012) Chordoma: Current Concepts, Management, and Future Directions. Lancet Oncology, 13, e69-e76. https://doi.org/10.1016/S1470-2045(11)70337-0
|
[8]
|
Stiller, C., Trama, A., Serraino, D., Rossi, S., Navarro, C., Chirlaque, M. and Casali, P. (2013) RARECARE Working Group. Descriptive Epidemiology of Sarcomas in Europe: Report from the RARECARE Project. European Journal of Cancer, 49, 684-695. https://doi.org/10.1016/j.ejca.2012.09.011
|
[9]
|
Müller, H. (1858) Ueber das Vorkommen von Resten der Chorda Dorsalis bei Menschen nach der Geburt, und über ihr Verhaltnis zu den Gallertgeschwulsten der Clivus. Zeitschrift fur Rationelle Medicin, 2, 202-229.
|
[10]
|
Urban, J., Roberts, S. and Ralphs, J. (2000) The Nucleus of the Intervertebral Disc from Development to Degeneration. American Zoologist, 40, 53-61.
https://doi.org/10.1093/icb/40.1.53
|
[11]
|
Maria Frezzaa, A., Bottab, L., Tramab, A., Dei Tos, A.P. and Stacchiottia, S. (2019) Chordoma: Update on Disease, Epidemiology, Biology and Medical Therapies. Current Opinion in Oncology, 31, 114-120.
https://doi.org/10.1097/CCO.0000000000000502
|
[12]
|
Chagnon, S., Vallee, C., Blery, M. and Chevrot, A. (1997) Chordome. EMC Ap. Locomoteur, 31520-A35.
|
[13]
|
Bergh, P., Kindblom, L.G., Gunterberg, B., Remotti, F., Ryd, W. and Meis-Kindblom, J.M. (2000) Prognostic Factors in Chordoma of the Sacrum and Mobile Spine: A Study of 39 Patients. Cancer, 88, 2122-2134.
https://doi.org/10.1002/(SICI)1097-0142(20000501)88:9<2122::AID-CNCR19>3.0.CO;2-1
|
[14]
|
Kaiser, T.E., Pritchard, D.J. and Unni, K.K. (1984) Clinicopathologic Study of Sacrococcygeal Chordoma. Cancer, 53, 2574-2578.
https://doi.org/10.1002/1097-0142(19840601)53:11<2574::AID-CNCR2820531136>3.0.CO;2-5
|
[15]
|
Gray, S.W., Singhabhandhu, B., Smith, R.A. and Skandalakis, J.E. (1975) Sacrococcygeal Chordoma: Report of a Case and Review of the Literature. Surgery, 78, 573-582.
|
[16]
|
Fourney, D.R. and Gokaslan, Z.L. (2003) Current Management of Sacral Chordoma. Neurosurg Focus, 15, 1-5. https://doi.org/10.3171/foc.2003.15.2.9
|
[17]
|
Kitai, R., Yoshida, K., Kubota, T., Sato, K., Handa, Y., Kasahara, K., et al. (2005) Clival Chordoma Manifesting as Nasal Bleeding: A Case Report. Neuroradiology, 47, 368-371. https://doi.org/10.1007/s00234-005-1367-7
|
[18]
|
Levi, A.D., Kucharczyk, W., Lang, A.P. and Schutz, H. (1991) Clival Chordoma Presenting with Acute Brain Stem Hemorrhage. Canadian Journal of Neurological Sciences, 18, 515-518. https://doi.org/10.1017/S0317167100032273
|
[19]
|
Erdem, E., Angtuaco, E.C., Van Hemert, R., Park, J.S. and Al-Mefty, O. (2003) Comprehensive Review of Intracranial Chordoma1 Embryonic Origin, Clinical Manifestations, and Histopathologic Features of Intracranial Chordomas. RadioGraphics, 23, 995-1009. https://doi.org/10.1148/rg.234025176
|
[20]
|
Llauger, J., Palmer, J., Amores, S., Bague, S. and Camins, A. (2000) Primary Tumors of the Sacrum: Diagnostic Imaging. American Journal of Roentgenology, 174, 417-424. https://doi.org/10.2214/ajr.174.2.1740417
|
[21]
|
Rossleigh, M.A., Smith, J. and Yeh, S.D. (1986) Scintigraphic Features of Primary Sacral Tumors. Journal of Nuclear Medicine, 27, 627-630.
|
[22]
|
Jambhekar, N.A., Rekhi, B., Thorat, K., Dikshit, R., Agrawal, M. and Puri, A. (2010) Revisiting Chordoma with Brachyury, a “New Age” Marker: Analysis of a Validation Study on 51 Cases. Archives of Pathology & Laboratory Medicine, 134, 1181-1187.
|
[23]
|
Miettinen, M., Wang, Z., Lasota, J., Heery, C., Schlom, J. and Palena, C. (2015) Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: an Immunohistochemical Study of 5229 Cases. The American Journal of Surgical Pathology, 39, 1305-1312. https://doi.org/10.1097/PAS.0000000000000462
|
[24]
|
Vujovic, S., Henderson, S., Presneau, N., Odell, E., Jacques, T.S., Tirabosco, R., Boshoff, C. and Flanagan, A.M. (2006) Brachyury, a Crucial Regulator of Notochordal Development, Is a Novel Biomarker for Chordomas. The Journal of Pathology, 209, 157-165. https://doi.org/10.1002/path.1969
|
[25]
|
Oakley, G.J., Fuhrer, K. and Seethala, R.R. (2008) Brachyury SOX-9, and Podoplanin, New Markers in the Skull Base Chordoma vs Chondrosarcoma Differential: A Tissue Microarray-Based Comparative Analysis. Modern Pathology, 21, 1461-1469. https://doi.org/10.1038/modpathol.2008.144
|
[26]
|
Wasserman, J.K., Gravel, D. and Purgina, B. (2018) Chordoma of the Head and Neck: A Review. Head and Neck Pathology, 12, 261-268.
https://doi.org/10.1007/s12105-017-0860-8
|
[27]
|
Hug, E.B., Loredo, L.N., Slater, J.D., De Vries, A., Grove, R.I., Schaefer, R.A., et al. (1999) Proton Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base. Journal of Neurosurgery, 91, 432-439.
https://doi.org/10.3171/jns.1999.91.3.0432
|
[28]
|
Boriani, S., Bandiera, S., Biagini, R., Bacchini, P., Boriani, L., Cappuccio, M., Chevalley, F., Gasbarrini, A., Picci, P. and Weinstein, J.N. (2006) Chordoma of the Mobile Spine: Fifty Years of Experience. Spine, 31, 493-503.
https://doi.org/10.1097/01.brs.0000200038.30869.27
|
[29]
|
Dauty, M., Faure, A., Le Neel, J.C., Moreau, A. and Dubois, C. (2000) Chordome Sacré: Une Pathologie Rare. Annales de Réadaptation et de Médecine Physique, 43, 84-88. https://doi.org/10.1016/S0168-6054(00)88732-2
|
[30]
|
Dial, B.L., Kerr, D.L., Lazarides, A.L., Catanzano, A.A., Green, C.L., Risoli Jr., T., Blazer, D.G., Goodwin, R.C., Brigman, B.E., Eward, W.C., Larrier, N.A., Kirsch, D.G. and Mendoza-Lattes, S.A. (2020) The Role of Radiotherapy for Chordoma Patients Managed With Surgery Analysis of the National Cancer Database. SPINE, 45, E742-E751. https://doi.org/10.1097/BRS.0000000000003406
|
[31]
|
Carpentier, A., Polivka, M., Blanquet, A., Lot, G. and George, B. (2002) Suboccipital and Cervical Chordomas: The Value of Aggressive Treatment at First Presentation of the Disease. Journal of Neurosurgery, 97, 1070-1077.
https://doi.org/10.3171/jns.2002.97.5.1070
|
[32]
|
Terahara, A., Niemierko, A., Goitein, M., Finkelstein, D., Hug, E., Liebsch, N., et al. (1999) Analysis of the Relationship between Tumor Dose Inhomogeneity and Local Control in Patients with Skull Base Chordoma. International Journal of Radiation Oncology, Biology, Physics, 45, 351-358.
https://doi.org/10.1016/S0360-3016(99)00146-7
|
[33]
|
Noel, G., Feuvret, L., Calugaru, V., Dhermain, F., Mammar, H., Haie-Méder, C., et al. (2005) Chordomas of the Base of the Skull and Upper Cervical Spine. One Hundred Patients Irradiated by a 3D Conformal Technique Combining Photon and Proton Beams. Acta Oncologica, 44, 700-708.
https://doi.org/10.1080/02841860500326257
|
[34]
|
De Laney, T.F., Liebsch, N.J., Pedlow, F.X., Adams, J., Dean, S., Yeap, B.Y., et al. (2009) Phase II Study of High-Dose Photon/Proton Radiotherapy in the Management of Spine Sarcomas. International Journal of Radiation Oncology, Biology, Physics, 74, 732-739. https://doi.org/10.1016/j.ijrobp.2008.08.058
|
[35]
|
Rutz, H.P., Weber, D.C., Sugahara, S., Timmermann, B., Lomax, A.J., Bolsi, A., et al. (2007) Extracranial Chordoma: Outcome in Patients Treated with Function-Preserving Surgery Followed by Spot-Scanning Proton Beam Irradiation. International Journal of Radiation Oncology, Biology, Physics, 67, 512-520.
https://doi.org/10.1016/j.ijrobp.2006.08.052
|
[36]
|
Park, L., Delaney, T.F., Liebsch, N.J., Hornicek, F.J., Goldberg, S., Mankin, H., et al. (2006) Sacral Chordomas: Impact of High-Dose Proton/Photon-Beam Radiation Therapy Combined with or without Surgery for Primary versus Recurrent Tumor. International Journal of Radiation Oncology, Biology, Physics, 65, 1514-1521.
https://doi.org/10.1016/j.ijrobp.2006.02.059
|
[37]
|
Imai, R., Kamada, T., Tsuji, H., Sugawara, S., Serizawa, I., Tsujii, H., et al. (2010) Effect of Carbon Ion Radiotherapy for Sacral Chordoma: Results of Phase I-II and Phase II Clinical Trials. International Journal of Radiation Oncology, Biology, Physics, 77, 1470-1476. https://doi.org/10.1016/j.ijrobp.2009.06.048
|
[38]
|
Kabolizadeh, P., Chen, Y.L., Liebsch, N., Hornicek, F.J., Schwab, J.H., Choy, E., et al. (2017) Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated with Definitive High-Dose Photon/Proton Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 97, 254-262.
https://doi.org/10.1016/j.ijrobp.2016.10.006
|
[39]
|
Jacob, H.E. (1994) Chemotherapy for Cranial Base Tumors. Journal of Neuro-Oncology, 20, 327-335. https://doi.org/10.1007/BF01053047
|
[40]
|
Stacchiotti, S., Longhi, A., Ferraresi, V., Grignani, G., Comandone, A., StuppAlexia, Bertuzzi, R., et al. (2012) Phase II Study of Imatinib in Advanced Chordoma. Journal of Clinical Oncology, 30, 914-920. https://doi.org/10.1200/JCO.2011.35.3656
|
[41]
|
Stacchiotti, S., Marrari, A., Tamborini, E., Palassini, E., Virdis, E., Messina, A., et al. (2009) Response to Imatinib Plus Sirolimus in Advanced Chordoma. Annals of Oncology, 20, 1886-1894. https://doi.org/10.1093/annonc/mdp210
|
[42]
|
Christopher, R. (2016) Chordoma: The Quest for Better Treatment Options. Oncology and Therapy, 4, 35-51. https://doi.org/10.1007/s40487-016-0016-0
|
[43]
|
George, S., Merriam, P., Maki, R.G., Van den Abbeele, A.D., Yap, J.T., Akhurst, T. Harmon, D.C., et al. (2009) Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas. Journal of Clinical Oncology, 27, 3154-3160. https://doi.org/10.1200/JCO.2008.20.9890
|
[44]
|
Liu, C., Jia, Q., Wei, H.F., Yang, X.H., Liu, T.L., Zhao, J., et al. (2020) Apatinib in Patients with Advanced Chordoma: A Single-Arm, Single-Centre, Phase 2 Study. Lancet Oncology, 21, 1244-1252. https://doi.org/10.1016/S1470-2045(20)30466-6
|